Patent details
301206 Product Name: melphalan flufenamide hydrochloride
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 301206
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP2701720
- Status:
- SPC granted but not yet in force
- Application number:
- 301206
- Procedural language:
- Dutch
- First Applicant Residence Country:
- Sweden (SE)
Marketing Authorization
- Marketing Authorization Number:
- EU/1/22/1669
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 18/08/2022
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 13/12/2022
- First Marketing Authorization date:
- 18/08/2022
- Grant date:
- 24/01/2023
- Activation date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 13/12/2022
- SPC/SPC Extension Expiration Date:
- 24/04/2037
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 21/08/2024
- Name:
- Oncopeptides Innovation AB
- Address:
- Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)
Historical Applicant/holder
- From:
- 21/08/2024
- To:
- 21/08/2024
- Name:
- Oncopeptides AB
- Address:
- Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)
- From:
- 13/12/2022
- To:
- 21/08/2024
- Name:
- Oncopeptides AB
- Address:
- Västra Trädgärdsgatan 15, 111 53, Stockholm, Sweden (SE)
Agent
- Name:
- ir. A. Blokland c.s.
- From:
- 13/12/2022
- Address:
- Algemeen Octrooi- en Merkenbureau B.V. Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- CO
- Journal edition number:
- 35/24
- Publication date:
- 28/08/2024
- Description:
- Changes in the Netherlands Patent Register
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 04/23
- Publication date:
- 25/01/2023
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 50/22
- Publication date:
- 14/12/2022
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of Address
- Change Kind/ Decision Type:
- Owner
- Deed Number:
- RC202401515A
- Date Registered:
- 21/08/2024
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. A. Blokland c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of owner(s)
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC202401515B
- Date Registered:
- 21/08/2024
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. A. Blokland c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Oncopeptides Innovation AB
- Address:
- Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 30/04/2032
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 1600 Euro
- Last Annual Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 24/01/2023 | Outgoing Correspondence | Decision grant | 1 | /1/2/3/2/4/0800842321/docs/301206_0_527643l504a.pdf | ||
| 24/01/2023 | Certificate | Certificate | 1 | /1/2/3/2/4/0800842321/docs/301206_1_spcmedcertificate20230124094133456.pdf | ||
| 14/12/2022 | Outgoing Correspondence | Confirmation receipt request | 1 | /1/2/3/2/4/0800842321/docs/301206_10_519937l174.pdf | ||
| 13/12/2022 | Application Form | First filed application form | 3 | /1/2/3/2/4/0800842321/docs/301206_2_applicationform20221213025446859.pdf | ||
| 13/12/2022 | SPC Documents | Marketing Authorization SPC | 3 | /1/2/3/2/4/0800842321/docs/301206_3_supplprotectioncertificate20221213032838864.pdf | ||
| 13/12/2022 | SPC Documents | Annex SPC | 46 | /1/2/3/2/4/0800842321/docs/301206_4_supplprotectioncertificate20221213033201359.pdf | ||
| 13/12/2022 | SPC Documents | Accompanying letter SPC | 3 | /1/2/3/2/4/0800842321/docs/301206_5_supplprotectioncertificate20221213032943473.pdf | ||
| 13/12/2022 | SPC Documents | Annex SPC | 12 | /1/2/3/2/4/0800842321/docs/301206_6_supplprotectioncertificate20221213033036310.pdf | ||
| 13/12/2022 | SPC Documents | Annex SPC | 2 | /1/2/3/2/4/0800842321/docs/301206_7_supplprotectioncertificate20221213033606421.pdf | ||
| 13/12/2022 | SPC Documents | Annex SPC | 13 | /1/2/3/2/4/0800842321/docs/301206_8_supplprotectioncertificate20221213033606457.pdf | ||
| 13/12/2022 | SPC Documents | Summary of the characteristics of the product | 16 | /1/2/3/2/4/0800842321/docs/301206_9_supplprotectioncertificate20221213033606381.pdf |